copper benzochlorin: structure given in first source; a photosensitizer for use in photodynamic therapy
ID Source | ID |
---|---|
PubMed CID | 164462 |
MeSH ID | M0217383 |
Synonym |
---|
145582-83-8 |
copper benzochlorin |
copper(1+), (n-methyl-n-((5,6,10,11,15,16,22,22-octaethyl-4,7:14,17-diimino-2,21-methano-9,12-nitrilo-12h-1-benzazacyclononadecin-3-yl)methylene)methanaminivmato(2-))-, chloride, (sp-4-1)- |
copper(ii) alpha-meso-n,n'-dimethyloctaethylbenzochlorin iminium chloride |
cds1 photosensitizer |
copper;n,n-dimethyl-1-(12,13,17,18,22,23,27,27-octaethyl-8,24,25-triaza-26-azanidahexacyclo[19.2.1.16,9.111,14.116,19.02,7]heptacosa-1(24),2(7),3,5,8,11,13,15,17,19(25),20,22-dodecaen-10-ylidene)methanamine;chloride |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (85.71) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.13) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |